Vascular Effects of Hesperidin in Metabolic Syndrome

Clinical trial NCT00914251 · UNKNOWN

Trial details

NCT number: NCT00914251
Sponsor: University of Rome Tor Vergata
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Endothelial Dysfunction Metabolic Syndrome

Start date: 2008-11-01
Primary completion: 2009-03-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.